# ASF1A

## Overview
ASF1A is a gene that encodes the anti-silencing function 1A histone chaperone, a protein integral to chromatin dynamics and genomic stability. This protein is categorized as a histone chaperone, which plays a pivotal role in the assembly and disassembly of nucleosomes, thereby influencing DNA replication, repair, and transcription regulation. ASF1A facilitates the deposition of histones H3.1 and H3.3 into chromatin, working in conjunction with chromatin assembly factor 1 (CAF-1) and histone repression A factor (HIRA) during different phases of nucleosome assembly (Galvani2008In). The protein's structure is characterized by a conserved N-terminal domain that interacts with histones and other proteins, forming complexes essential for chromatin assembly and regulation (Mousson2005Structural; Tang2006Structure). ASF1A's involvement in chromatin dynamics is crucial for maintaining genomic stability, and its dysregulation is associated with various cancers, making it a potential target for therapeutic interventions (Wu2019ASF1a; Liang2017Histone).

## Structure
ASF1A is a histone chaperone with a highly conserved N-terminal domain that plays a crucial role in its interaction with histones and other proteins. The primary structure of ASF1A consists of a sequence of amino acids forming the protein, with the N-terminal domain comprising residues 1-156 (Mousson2005Structural). The secondary structure includes 10 β-strands organized into an immunoglobulin-like fold with three β-sheets and two short α-helices (Mousson2005Structural). This domain is described as a monomeric globular domain with limited internal motions and significant flexibility in certain loop regions (Mousson2005Structural).

The tertiary structure of ASF1A is characterized by an elongated immunoglobulin-like β sandwich fold, consistent with structures observed in both human ASF1a and yeast Asf1p (Tang2006Structure). ASF1A functions as a homodimer, indicating a quaternary structure, although specific details on this aspect are not extensively covered in the provided context.

ASF1A interacts with histones H3 and H4, forming complexes with other proteins like HIRA and CAF-1, which are involved in chromatin assembly and regulation (Tang2006Structure). The protein's interaction with histone H3 involves a conserved hydrophobic groove surrounded by charged residues, crucial for binding (Mousson2005Structural). Common post-translational modifications, such as phosphorylation, may affect ASF1A's activity and interactions, although specific modifications are not detailed in the context. Splice variant isoforms may exist, potentially altering its functional properties, but these are not explicitly mentioned in the provided information.

## Function
ASF1A is a histone chaperone involved in the assembly and disassembly of nucleosomes, playing a critical role in DNA replication, repair, and transcription regulation. It facilitates the deposition of histones H3.1 and H3.3 into chromatin, working in conjunction with chromatin assembly factor 1 (CAF-1) during DNA synthesis-coupled nucleosome assembly and with histone repression A factor (HIRA) during DNA synthesis-independent assembly (Galvani2008In). ASF1A is essential for the acetylation of H3K56, a histone modification important for maintaining pluripotency in embryonic stem cells and reprogramming somatic cells into induced pluripotent stem cells (GonzalezMuñoz2014Histone).

ASF1A interacts with histone H3 through specific arginine residues, which are crucial for its function in nucleosome assembly (Mousson2005Structural). It is also a substrate for tousled-like kinases (Tlks), which phosphorylate ASF1A during the S phase of the cell cycle, linking it to DNA replication and the DNA damage response (Silljé2001Identification). ASF1A's role in chromatin dynamics is vital for genomic stability and proper cell cycle progression, as its depletion leads to cell cycle arrest in the S phase (Galvani2008In).

## Clinical Significance
ASF1A is implicated in the progression of various cancers due to its role in chromatin assembly and gene transcription regulation. Overexpression of ASF1A is observed in several cancers, including hepatocellular carcinoma (HCC), prostate cancer, gastric cancer, and breast cancer, where it is associated with poor clinical outcomes. In HCC, high ASF1A expression correlates with shorter disease-free survival and overall survival, suggesting its potential as a prognostic marker (Wu2019ASF1a). ASF1A overexpression is also linked to a malignant phenotype in gastrointestinal cancers, such as gastric and colorectal cancers, where it promotes tumor growth and metastasis by interacting with β-catenin and enhancing the transcription of target genes involved in cancer progression (Liang2017Histone).

In lung adenocarcinoma, ASF1A is identified as a regulator of tumor immunity. Its deficiency enhances sensitivity to anti-PD-1 immunotherapy, indicating that ASF1A may suppress tumor immunity and that its inhibition could improve immunotherapeutic outcomes (Li2020In). ASF1A's role in cancer is further underscored by its involvement in the p53/p21 pathway, where its inhibition leads to growth arrest and senescence in cancer cells, highlighting its potential as a therapeutic target (Wu2019ASF1a).

## Interactions
ASF1A, a histone chaperone, engages in several critical interactions with other proteins, playing a significant role in chromatin assembly and DNA replication. ASF1A forms a complex with the HIRA protein, where the B-domain of HIRA binds to the N-terminal core domain of ASF1A. This interaction involves hydrogen bonds, salt bridges, and hydrophobic interactions, with key residues such as Val60, Val62, and Phe72 from ASF1A forming van der Waals interactions with HIRA residues Ile461 and Pro463 (Tang2006Structure). ASF1A also interacts with the p60 subunit of CAF-1 through B-domain-like motifs, which bind to the same surface on ASF1A as HIRA, resulting in mutually exclusive binding (Tang2006Structure).

ASF1A's interaction with histone H3 is characterized by binding to a segment of histone H3 (residues 122-135), facilitated by a conserved hydrophobic groove on ASF1A. Mutations in ASF1A, such as V94R, disrupt this interaction, highlighting its importance for histone binding (Mousson2005Structural). ASF1A also interacts with the CBP bromodomain, enhancing CBP-mediated acetylation of histone H3 K56Ac, a process crucial for histone acetylation (Das2014Binding). These interactions underscore ASF1A's role in chromatin dynamics and genome stability.


## References


[1. (Wu2019ASF1a) Yujiao Wu, Xidan Li, Jingya Yu, Magnus Björkholm, and Dawei Xu. Asf1a inhibition induces p53-dependent growth arrest and senescence of cancer cells. Cell Death &amp; Disease, January 2019. URL: http://dx.doi.org/10.1038/s41419-019-1357-z, doi:10.1038/s41419-019-1357-z. This article has 27 citations.](https://doi.org/10.1038/s41419-019-1357-z)

[2. (Li2020In) Fei Li, Qingyuan Huang, Troy A. Luster, Hai Hu, Hua Zhang, Wai-Lung Ng, Alireza Khodadadi-Jamayran, Wei Wang, Ting Chen, Jiehui Deng, Michela Ranieri, Zhaoyuan Fang, Val Pyon, Catríona M. Dowling, Ece Bagdatlioglu, Christina Almonte, Kristen Labbe, Heather Silver, Alexandra R. Rabin, Kandarp Jani, Aristotelis Tsirigos, Thales Papagiannakopoulos, Peter S. Hammerman, Vamsidhar Velcheti, Gordon J. Freeman, Jun Qi, George Miller, and Kwok-Kin Wong. In vivo epigenetic crispr screen identifies asf1a as an immunotherapeutic target in kras-mutant lung adenocarcinoma. Cancer Discovery, 10(2):270–287, February 2020. URL: http://dx.doi.org/10.1158/2159-8290.CD-19-0780, doi:10.1158/2159-8290.cd-19-0780. This article has 155 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1158/2159-8290.CD-19-0780)

[3. (Silljé2001Identification) Herman H.W. Silljé and Erich A. Nigg. Identification of human asf1 chromatin assembly factors as substrates of tousled-like kinases. Current Biology, 11(13):1068–1073, July 2001. URL: http://dx.doi.org/10.1016/s0960-9822(01)00298-6, doi:10.1016/s0960-9822(01)00298-6. This article has 146 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/s0960-9822(01)00298-6)

[4. (GonzalezMuñoz2014Histone) Elena Gonzalez-Muñoz, Yohanna Arboleda-Estudillo, Hasan H. Otu, and Jose B. Cibelli. Histone chaperone asf1a is required for maintenance of pluripotency and cellular reprogramming. Science, 345(6198):822–825, August 2014. URL: http://dx.doi.org/10.1126/science.1254745, doi:10.1126/science.1254745. This article has 68 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1126/science.1254745)

[5. (Das2014Binding) Chandrima Das, Siddhartha Roy, Sarita Namjoshi, Christopher S. Malarkey, David N. M. Jones, Tatiana G. Kutateladze, Mair E. A. Churchill, and Jessica K. Tyler. Binding of the histone chaperone asf1 to the cbp bromodomain promotes histone acetylation. Proceedings of the National Academy of Sciences, March 2014. URL: http://dx.doi.org/10.1073/pnas.1319122111, doi:10.1073/pnas.1319122111. This article has 50 citations.](https://doi.org/10.1073/pnas.1319122111)

[6. (Galvani2008In) Angélique Galvani, Régis Courbeyrette, Morgane Agez, Françoise Ochsenbein, Carl Mann, and Jean-Yves Thuret. In vivo study of the nucleosome assembly functions of asf1 histone chaperones in human cells. Molecular and Cellular Biology, 28(11):3672–3685, June 2008. URL: http://dx.doi.org/10.1128/mcb.00510-07, doi:10.1128/mcb.00510-07. This article has 38 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/mcb.00510-07)

[7. (Mousson2005Structural) Florence Mousson, Aurélie Lautrette, Jean-Yves Thuret, Morgane Agez, Régis Courbeyrette, Béatrice Amigues, Emmanuelle Becker, Jean-Michel Neumann, Raphaël Guerois, Carl Mann, and Françoise Ochsenbein. Structural basis for the interaction of asf1 with histone h3 and its functional implications. Proceedings of the National Academy of Sciences, 102(17):5975–5980, April 2005. URL: http://dx.doi.org/10.1073/pnas.0500149102, doi:10.1073/pnas.0500149102. This article has 114 citations.](https://doi.org/10.1073/pnas.0500149102)

[8. (Liang2017Histone) Xiuming Liang, Xiaotian Yuan, Jingya Yu, Yujiao Wu, Kailin Li, Chao Sun, Shuyan Li, Li Shen, Feng Kong, Jihui Jia, Magnus Björkholm, and Dawei Xu. Histone chaperone asf1a predicts poor outcomes for patients with gastrointestinal cancer and drives cancer progression by stimulating transcription of β-catenin target genes. EBioMedicine, 21:104–116, July 2017. URL: http://dx.doi.org/10.1016/j.ebiom.2017.06.007, doi:10.1016/j.ebiom.2017.06.007. This article has 23 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.ebiom.2017.06.007)

[9. (Tang2006Structure) Yong Tang, Maxim V Poustovoitov, Kehao Zhao, Megan Garfinkel, Adrian Canutescu, Roland Dunbrack, Peter D Adams, and Ronen Marmorstein. Structure of a human asf1a–hira complex and insights into specificity of histone chaperone complex assembly. Nature Structural &amp; Molecular Biology, 13(10):921–929, September 2006. URL: http://dx.doi.org/10.1038/nsmb1147, doi:10.1038/nsmb1147. This article has 159 citations.](https://doi.org/10.1038/nsmb1147)